Anisha Rao

Contributions

Could Vitiligo Support Groups Improve Quality of Life?

Although vitiligo is not considered life-threatening and is not associated with severe physical symptoms, the condition can still significantly impact patients’ quality of life. Due to stares and the disease’s unpredictable course, many vitiligo patients feel distressed and stigmatized by their condition. Vitiligo support groups may alleviate these feelings and potentially improve the quality of...

Assessing Vitiligo Treatment Delay Causes

Many vitiligo patients experience access to care issues, such as a lack of insurance, language barriers, geographic proximity to a provider, and more. Unfortunately, these barriers lead to vitiligo treatment delays. Delayed treatment can interfere with disease stabilization and repigmentation efficacy as early-stage interventions are more effective. Given that patients of color with vitiligo experience...

Vitiligo Comorbidities Vary by Race, Ethnicity, and Sex

Vitiligo is a common skin condition associated with many comorbid autoimmune, dermatological, and systemic diseases. These conditions include diabetes mellitus, rheumatoid arthritis, Addison’s disease, inflammatory bowel disease, scleroderma, and more. However, the researchers recognized that very few studies investigated the associations between vitiligo and various medical conditions. Therefore, this study, published by The Journal of...

Insurance Plans Inadequately Cover Vitiligo Treatments

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_spacing=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_shadow=”none” column_border_radius=”none” column_link_target=”_self” column_position=”default” gradient_direction=”left_to_right” overlay_strength=”0.3″ width=”1/1″ tablet_width_inherit=”default” tablet_text_alignment=”default” phone_text_alignment=”default” animation_type=”default” bg_image_animation=”none” border_type=”simple” column_border_width=”none” column_border_style=”solid”][vc_column_text]Health insurance coverage is strongly related to better health care outcomes. Individuals without insurance or those who...

Virtual Group Visits Alleviate Pediatric Vitiligo Distress

In the medical community, an often overlooked yet important issue is the psychosocial distress experienced by people of color with vitiligo. Although vitiligo affects all racial groups similarly, this skin pigmentation condition is much more noticeable in people with darker skin.  Racially diverse children are more likely to encounter barriers to accessing care at pediatric...

The Effects of a Transthyretin Gene Variant in Black Americans

Transthyretin (TTR) gene variants may increase the risk of heart failure and other cardiac complications. A specific TTR gene variant at position 122 (V142I) is particularly common among middle-aged Black patients. The TTR V142I variant is characterized by a valine-to-isoleucine substitution and is a significant cause of cardiac amyloidosis. Although research is ongoing, one particular...

Diagnosing Older Patients with ATTR-CM

Transthyretin amyloidosis cardiomyopathy (ATTR-CM) is a rare, age-related, debilitating disease. In particular, the wild-type (ATTRwt) is often diagnosed in older patients who also present symptoms of other comorbidities. One review, published in Frontiers in Cardiovascular Medicine, discussed the challenges when diagnosing older patients with ATTR-CM. 13% of patients over 60 hospitalized with heart failure with...

Heart Failure Disparities and Comorbidities Among Older Patients

The number of older patients in the United States is expected to increase by 69% between 2020 and 2060. In addition, ethnic and racial groups are expected to become the racial majority within the next 35 years. However, heart failure disparities and comorbidity disparities span across different ethnic groups. Socioeconomic factors, race, and conditions associated...

Eliminating Multiple Myeloma Therapy Racial Disparities

Multiple Myeloma Status Quo Over 30,000 Americans are diagnosed with multiple myeloma each year. And more than 12,500 Americans pass away due to multiple myeloma annually. Multiple myeloma is a cancer of plasma cells. With multiple myeloma, the bone marrow consists of excess plasma cells associated with monoclonal protein in the blood and/or urine. Clinical...
<<
  • 1
  • 2
>>

Categories

Stay informed on the latest health disparities research, cultural sensitivity education, and how you can help improve patient outcomes.
This field is for validation purposes and should be left unchanged.